Hepatocellular Carcinoma Clinical Trials in Beijing, Beijing Municipality
28 recruitingBeijing, Beijing Municipality, China
Showing 1–20 of 28 trials
Recruiting
Phase 1Phase 2
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Hepatocellular CarcinomaSolid TumorsNon-small Cell Lung Cancer+1 more
3D Medicines (Sichuan) Co., Ltd.170 enrolled23 locationsNCT05024214
Recruiting
Phase 1Phase 2
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Akeso280 enrolled2 locationsNCT06530251
Recruiting
Phase 2
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd141 enrolled51 locationsNCT07327034
Recruiting
Phase 2
NWRD06 DNA Plasmid for HCC After Curative Resection.
Hepatocellular Carcinoma (HCC)
Newish Technology (Beijing) Co., Ltd.30 enrolled6 locationsNCT07324304
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled4 locationsNCT07239245
Recruiting
Phase 2
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd.72 enrolled12 locationsNCT06954467
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
Liver CancerSurgeryHepatocellular Carcinoma+1 more
Sun Yat-sen University326 enrolled1 locationNCT06898398
Recruiting
HAIC Compared With TACE in Huge Hepatocellular Carcinoma
Liver CancerHepatocellular CarcinomaHepatic Chemotherapy
Sun Yat-sen University664 enrolled1 locationNCT06641713
Recruiting
Phase 1
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
AbbVie20 enrolled11 locationsNCT06487559
Recruiting
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
Hepatocellular CarcinomaPD-1 InhibitorLenvatinib+1 more
Sun Yat-sen University300 enrolled1 locationNCT06333561
Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Lung CancerAdvanced Hepatocellular CarcinomaOligometastasis+2 more
Sun Yat-sen University470 enrolled1 locationNCT06644430
Recruiting
Phase 1
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000
Recruiting
Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
Hepatocellular Carcinoma Stage III
Chinese PLA General Hospital500 enrolled1 locationNCT06559761
Recruiting
Phase 2
Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma
Hepatocellular CarcinomaAdebrelimab
Tianjin Medical University Cancer Institute and Hospital40 enrolled4 locationsNCT06405061
Recruiting
Phase 1
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Hepatocellular Carcinoma
Peking Union Medical College Hospital40 enrolled1 locationNCT06363006
Recruiting
Not Applicable
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
Hepatocellular Carcinoma
Zhongda Hospital188 enrolled2 locationsNCT06190665
Recruiting
Phase 3
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.480 enrolled67 locationsNCT05862337
Recruiting
Phase 2Phase 3
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
Hepatocellular Carcinoma
Shandong New Time Pharmaceutical Co., LTD576 enrolled5 locationsNCT05408221
Recruiting
Not Applicable
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
Hepatocellular Carcinoma
Beijing Hospital88 enrolled1 locationNCT05738980
Recruiting
Not Applicable
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
Hepatocellular Carcinoma
Chinese PLA General Hospital1,134 enrolled1 locationNCT04365751